Duncker Streett & CO Inc Moderna, Inc. Transaction History

Duncker Streett & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$69.51 - $104.43 $3,823 - $5,743	-55 Reduced 36.67%	95 $9,000
Q3 2023 Oct 26, 2023	SELL	$96.41 - $126.61 $6,748 - $8,862	-70 Reduced 31.82%	150 $15,000
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $165,298 - $271,852	-1,400 Reduced 86.42%	220 $26,000
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $151,752 - $282,060	1,200 Added 285.71%	1,620 $279,000
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $39,518 - $64,489	-175 Reduced 29.41%	420 $107,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $8,188 - $13,948	75 Added 14.42%	595 $78,000
Q4 2020 Feb 02, 2021	BUY	$65.74 - $169.86 $30,569 - $78,984	465 Added 845.45%	520 $54,000
Q3 2020 Oct 28, 2020	BUY	$54.34 - $94.85 $2,988 - $5,216	55 New	55 $4,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Duncker Streett & CO Inc with notifications on news.